Yifan Zhai

Yifan Zhai, M.D., Ph.D., our Chief Medical Officer, has over 25 years of experience in cancer research and new drug development. Over the course of her career, she has served in various roles at biotech and venture capital companies, including as President & Chief Executive Officer of Healthquest Pharma; General Manager of China at Apricus Biosciences; Chief Scientific Officer of Celladon Corporation, China; Executive Director of Anaborex (Shanghai) R&D Co.,Ltd.; Chief Scientific Officer at Oncomax Acquisition Corp.; President of HealthQuest Inc.; Director at Exelixis; Senior Research Scientist at Bayer Pharmaceuticals; and Scientist at Human Genome Sciences, now GlaxoSmithKline. Early in her career, Dr. Zhai was the Biotechnology Fellow with Dr. Steven Rosenburg at Surgery Branch, National Cancer Institute. Dr. Zhai was the President of Chinese Biopharmaceutical Association-US from 2009 to 2010. She has authored more than 27 academic papers, and is currently a Director of Healthquest Pharma. Dr. Zhai obtained her Doctor of Medicine degree from Sun Yat-sen University of Medical Sciences (renamed Sun Yat-sen University), and received her Ph.D. degree in Pharmacology and Toxicology from Michigan State University.

Yifan Zhai is the Chief Medical Officer at Ascentage Pharma, based in United States, North America. With a background in Biotechnology, Yifan Zhai has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.